Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pfizer Raises FY2025 Adj EPS Guidance from $2.90-$3.10 to $3.00-$3.15 vs $3.04 Est; Affirms FY2025 Sales Guidance of $61.000B-$64.000B vs $62.879B Est

Author: Benzinga Newsdesk | November 04, 2025 06:45am
Pfizer (NYSE:PFE) raises FY2025 Adj EPS guidance from $2.90-$3.10 to $3.00-$3.15 vs $3.04 analyst estimate. Affirms FY2025 sales outlook from $61.000 billion-$64.000 billion to $61.000 billion-$64.000 billion vs $62.879 billion estimate.

Posted In: PFE


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist